We are taking a novel precision medicine approach to Alzheimer’s disease therapeutic development by targeting a known disease risk factor. Through this approach we aim to disrupt a fundamental disease process to prevent dementia before it occurs. This technology may also be used in the treatment of other neurodegenerative diseases.
